Death due to COVID-19 in an Infant with Combined Immunodeficiencies.
Death due to COVID-19 in an Infant with Combined Immunodeficiencies.
Endocr Metab Immune Disord Drug Targets. 2020 Oct 21;:
Authors: Ahanchian H, Moazzen N, Joghatayi SH, Saeidinia A, Khoshkhui M, Aelami MH, Rezaei N, Haghi NSM
Abstract
Novel coronavirus disease 2019 (COVID-19) has affected millions of people, which led to death especially in older cases with underlying diseases. Meanwhile pediatric patients with inherited defects of T cell should potentially be prone to viral diseases. Herein, we report an infant with combined immunodeficiency who died because of COVID-19.
PMID: 33087035 [PubMed - as supplied by publisher]
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Endocr Metab Immune Disord Drug Targets Source Type: research